Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Radiological Investigation II: MRI and Ventilation Perfusion Scan01:30

Radiological Investigation II: MRI and Ventilation Perfusion Scan

111
Description
Magnetic Resonance Imaging (MRI) and Ventilation Perfusion Scans are two radiological investigations that offer detailed diagnostic images of the body, particularly lung structures.
MRI
MRI uses magnetic fields and radiofrequency signals to distinguish between normal and abnormal tissues. This technology provides a more detailed diagnostic image than CT scans, enabling it to characterize pulmonary nodules, stage bronchogenic carcinoma, and evaluate inflammatory activity in...
111

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Association of a Polygenic Risk Score with Diagnosis and Outcomes in Idiopathic Pulmonary Fibrosis.

American journal of respiratory and critical care medicine·2026
Same author

Paraseptal Emphysema and Interstitial Lung Abnormalities in AGES-Reykjavik Study.

Annals of the American Thoracic Society·2026
Same author

Early Pulmonary Fibrosis is Defined by Niche- and Cell-Specific Molecular Programs.

bioRxiv : the preprint server for biology·2026
Same author

Performance of Age-Adjusted Whole Genome Sequencing Telomere Length in Idiopathic Pulmonary Fibrosis.

American journal of respiratory and critical care medicine·2026
Same author

Occupational inhaled exposures and risk of interstitial lung abnormalities in individuals with potential familial susceptibility to pulmonary fibrosis.

Thorax·2026
Same author

Adult life course trajectories of lung function and the development of interstitial lung abnormalities: the CARDIA lung study.

Respiratory research·2026
Same journal

Pneumonia Reimagined: Host, Microbe, and the Shifting Landscape of Disease.

Clinics in chest medicine·2026
Same journal

Advocacy in Pneumonia.

Clinics in chest medicine·2026
Same journal

Vaccines Against Pneumonia: Current Updates.

Clinics in chest medicine·2026
Same journal

Non-antibiotic Treatments for Pneumonia: Host-Directed Therapies, Next-Steps and Future Directions.

Clinics in chest medicine·2026
Same journal

Customizing Antibiotic Treatment for Pneumonia: Can We Have a Single Unified Algorithm for All Types of Pneumonia?

Clinics in chest medicine·2026
Same journal

The Role of Complex Digital Interventions to Improve Pneumonia Care.

Clinics in chest medicine·2026
See all related articles

Related Experiment Video

Updated: Jun 25, 2025

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
04:44

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Published on: June 16, 2020

19.9K

Interstitial Lung Abnormalities: Current Understanding.

Noriaki Wada1, Gary M Hunninghake2, Hiroto Hatabu1

  • 1Department of Radiology, Center for Pulmonary Functional Imaging, Brigham and Women's Hospital and Harvard Medical School, 75 Francis Street, Boston, MA 02115, USA.

Clinics in Chest Medicine
|May 30, 2024
PubMed
Summary
This summary is machine-generated.

Interstitial lung abnormalities (ILAs) are common CT findings linked to poor outcomes. A traction bronchiectasis index may help identify patients at high risk of progression to pulmonary fibrosis.

Keywords:
Clinical managementInterstitial lung abnormalitiesInterstitial lung diseasePulmonary fibrosisRisk stratificationTraction bronchiectasis/bronchiolectasis index

More Related Videos

Lung CT Segmentation to Identify Consolidations and Ground Glass Areas for Quantitative Assesment of SARS-CoV Pneumonia
08:05

Lung CT Segmentation to Identify Consolidations and Ground Glass Areas for Quantitative Assesment of SARS-CoV Pneumonia

Published on: December 19, 2020

14.1K
Protocol and Guidelines for Point-of-Care Lung Ultrasound in Diagnosing Neonatal Pulmonary Diseases Based on International Expert Consensus
06:15

Protocol and Guidelines for Point-of-Care Lung Ultrasound in Diagnosing Neonatal Pulmonary Diseases Based on International Expert Consensus

Published on: March 6, 2019

49.8K

Related Experiment Videos

Last Updated: Jun 25, 2025

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
04:44

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Published on: June 16, 2020

19.9K
Lung CT Segmentation to Identify Consolidations and Ground Glass Areas for Quantitative Assesment of SARS-CoV Pneumonia
08:05

Lung CT Segmentation to Identify Consolidations and Ground Glass Areas for Quantitative Assesment of SARS-CoV Pneumonia

Published on: December 19, 2020

14.1K
Protocol and Guidelines for Point-of-Care Lung Ultrasound in Diagnosing Neonatal Pulmonary Diseases Based on International Expert Consensus
06:15

Protocol and Guidelines for Point-of-Care Lung Ultrasound in Diagnosing Neonatal Pulmonary Diseases Based on International Expert Consensus

Published on: March 6, 2019

49.8K

Area of Science:

  • Radiology
  • Pulmonology
  • Medical Imaging

Background:

  • Interstitial lung abnormalities (ILAs) are frequently discovered incidentally on CT scans.
  • These abnormalities are associated with increased mortality, adverse clinical outcomes, and risk factors like age and smoking.
  • Accurate risk stratification is essential for managing ILAs, especially for predicting progression to pulmonary fibrosis.

Purpose of the Study:

  • To evaluate the utility of the traction bronchiectasis/bronchiolectasis index as an imaging biomarker.
  • To assess the prognostic value of this index for risk stratification in patients with ILAs.
  • To understand the spectrum of fibrosing interstitial lung diseases from ILAs to pulmonary fibrosis.

Main Methods:

  • Analysis of CT scans to identify and characterize interstitial lung abnormalities.
  • Assessment of the traction bronchiectasis/bronchiolectasis index in relation to clinical outcomes.
  • Correlation of imaging features with risk factors and mortality data.

Main Results:

  • The traction bronchiectasis/bronchiolectasis index shows promise as an imaging biomarker for prognostic risk stratification.
  • Nondependent abnormalities affecting >5% of a lung zone define ILAs.
  • Findings suggest a continuum from ILAs to fibrotic lung disease.

Conclusions:

  • The traction bronchiectasis/bronchiolectasis index is a valuable tool for risk stratification in ILAs.
  • Identifying high-risk ILAs can guide clinical management and predict progression to pulmonary fibrosis.
  • ILAs represent a spectrum of disease, potentially leading to fibrosing interstitial lung diseases.